Eastgate Biotech Corp
OTC:ETBI
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.0001
0.0045
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| US |
|
Eastgate Biotech Corp
OTC:ETBI
|
6.2m USD |
Loading...
|
|
| CA |
|
Relevium Technologies Inc
XTSX:RLV
|
12.2B CAD |
Loading...
|
|
| SE |
Z
|
Zinzino AB
STO:ZZ B
|
4.4B SEK |
Loading...
|
|
| CN |
S
|
Shanghai Aiyingshi Co Ltd
SSE:603214
|
2.5B CNY |
Loading...
|
|
| CN |
N
|
Nanjing Sinolife United Co Ltd
HKEX:3332
|
663.8m HKD |
Loading...
|
|
| CA |
|
Nova Cannabis Inc
TSX:NOVC
|
108.6m CAD |
Loading...
|
|
| US |
|
Franchise Group Inc
F:3HC
|
38.8m EUR |
Loading...
|
|
| JP |
|
Soiken Holdings Inc
TSE:2385
|
7B JPY |
Loading...
|
|
| HK |
|
Ausupreme International Holdings Ltd
HKEX:2031
|
251.5m HKD |
Loading...
|
|
| NZ |
|
Comvita Ltd
NZX:CVT
|
40.2m NZD |
Loading...
|
|
| CA |
O
|
Optimi Health Corp
CNSX:OPTI
|
30.4m CAD |
Loading...
|
Market Distribution
| Min | -4 087 900% |
| 30th Percentile | -5.1% |
| Median | 6% |
| 70th Percentile | 14.8% |
| Max | 1 032 600% |
Other Profitability Ratios
Eastgate Biotech Corp
Glance View
Eastgate Biotech Corp. engages in the development of novel formulations of natural compounds and pharmaceutical products. The company is headquartered in Salt Lake City, Utah. The company went IPO on 2014-01-16. The firm produces and distributes nutraceuticals that are based on natural therapies and absorbed naturally by the body. The company utilizes state-of-the-art nanotechnologies to deliver healthy alternatives to conventional pharmaceuticals that all-too-often create dangerous side-effects and unexpected consequences for those trying to attain and maintain healthy lives. The Company’s products include E-Drops NANO, Essential D, GluCora, VCleanzz, Cleanezze and Warts X. The firm develops products in which the components are incorporated into vehicles containing nano-sized delivery vectors, including oil droplets (nanoemulsions), polymeric particles (nanoparticles) and the combination of polymers and lipids with surfactants (hybrid nanoparticles, nanocapsules, mixed micelles).
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
Over the last 2 years, Eastgate Biotech Corp’s Operating Margin has increased from -7 566.7% to -4 837.8%. During this period, it reached a low of -7 566.7% on Jun 30, 2015 and a high of -2 807.7% on Mar 31, 2016.